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Abstract
To make progress in cartilage repair it is essential to optimize protocols for two-dimensional cell expansion. Chondrocytes
and SDSCs are promising cell sources for cartilage repair. We previously observed that priming with a specific growth factor
cocktail (1 ng/mL transforming growth factor-b1, 5 ng/mL basic fibroblast growth factor, and 10 ng/mL platelet-derived
growth factor-BB) in two-dimensional culture, led to significant improvement in mechanical and biochemical properties of
synovium-derived stem cell (SDSC)-seeded constructs. The current study assessed the effect of growth factor priming on the
proteome of canine chondrocytes and SDSCs. In particular, growth factor priming modulated the proteins associated with
the extracellular matrix in two-dimensional cultures of chondrocytes and SDSCs, inducing a partial dedifferentiation of
chondrocytes (most proteins associated with cartilage were down-regulated in primed chondrocytes) and a partial
differentiation of SDSCs (some collagen-related proteins were up-regulated in primed SDSCs). However, when chondrocytes
and SDSCs were grown in pellet culture, growth factor-primed cells maintained their chondrogenic potential with respect to
glycosaminoglycan and collagen production. In conclusion, the strength of the label-free proteomics technique is that it
allows for the determination of changes in components of the extracellular matrix proteome in chondrocytes and SDSCs in
response to growth factor priming, which could help in future tissue engineering strategies.
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Introduction
Adult articular cartilage has a very limited ability for natural
repair following injury, which has led to intense research toward
the development of cell-based therapies for cartilage repair [1].
Autologous chondrocyte implantation [2] is one of several current
strategies for cartilage repair. This technique requires surgical
invasion of normal articular cartilage. However, repair of large
cartilage defects is difficult due to the limited proliferative potential
of chondrocytes, a low number of healthy chondrocytes in
damaged cartilage, and donor-site morbidity [3].
To overcome these limitations, regenerative medicine strategies
using mesenchymal stem cells (MSCs) are being developed. MSCs
have the ability to differentiate in vitro into multiple cell types,
including chondrocytes, adipocytes, and osteocytes [4,5]. MSCs
are positive for some surface markers: CD73 (SH3/4), CD90
(Thy-1), and CD105 (endoglin), and negative for most hemato-
poietic lineage markers [6]. The clinical potential of MSCs as a
cell source for cartilage tissue engineering has been extensively
studied [7–9]. Many in vitro strategies have been utilized to induce
chondrogenic differentiation, including incubating with chemically
defined culture media [10], supplementing with selective growth
factor(s) [11], and co-culturing with mature chondrocytes [12].
MSCs can be isolated from several sources, including bone
marrow, adipose tissue, periosteum, and synovium [5,13–16]. Of
these MSC sources, the synovium is a particularly attractive source
of stem cells not only because of its superior chondrogenic capacity
[17], but also because it is easily regenerated after arthroscopic
harvesting [18]. Synovium-derived stem cells (SDSCs) have
potential for both in vitro cartilage tissue engineering [3,18] and
in vivo cartilage regeneration [19,20]. Several groups have shown
the multi-differentiation potential of SDSCs, thus confirming the
mesenchymal potential of SDSCs [5,21,22]. With appropriate
stimulation, SDSCs are capable of migrating into articular
cartilage defects and differentiating toward chondrocytes [23].
SDSCs may be a tissue-specific stem cell for tissue regeneration, as
they are capable of responding most aptly to signaling in the joint,
thus fostering cartilage tissue regeneration [16].
Our laboratory has shown that both chondrocytes and SDSCs
are promising cell sources for cartilage repair [3,24]. Cartilage
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tissues grown with chondrocytes have led to engineered cartilage
with superior mechanical properties, compared to tissues engi-
neered using stem cells, providing the primary motivation for the
chondrocyte cell source adopted in this study. As a result, parallel
studies were carried out using canine chondrocytes and SDSCs.
Adult canine cells were utilized since the dog represents an
important large preclinical animal model for musculoskeletal
research [25].
In order to create functional tissue, we used a growth factor
expansion protocol that we have observed to be efficacious for
expanding bovine chondrocytes and SDSCs in producing subse-
quent functional tissue matrix. Cell passaging and concurrent
priming with chemical factors are often necessary steps in cell-
based strategies for regenerative medicine [26]. The fact that
physiological formation of articular cartilage occurs through the
combination of several growth factors, and that both cartilage and
synovium originate from a common group of mesenchymal
precursor cells, suggests that cartilage formation utilizing SDSCs
occurs similarly [27,28]. The growth factor cocktail used to prime
both chondrocytes and SDSCs in this study consisted of
transforming growth factor beta 1 (TGF-b1), basic fibroblast
growth factor (bFGF), and platelet-derived growth factor-BB
(PDGF-BB) [29]. Previously, this growth factor cocktail was shown
to increase the proliferation rates and maintain the chondrogenic
potential of human articular chondrocytes [30].
To understand the effects of using this growth factor cocktail on
canine chondrocytes and SDSCs, we undertook comparative
proteomics analysis. This technique is potentially powerful for this
effort, since it quantifies differences in expression of proteins
among different biological states. It also allows for the detection of
proteins with post-translational modifications; this information is
not provided by genomic analyses. Recently, proteomics ap-
proaches were applied to studies with MSCs [31–33].
The objective of this study was to use comparative proteomics to
investigate the impact of growth factor priming on two-dimen-
sional (2D) canine chondrocyte and SDSC cultures, by identifying
differentially regulated cartilage proteins. Cells cultured without
growth factor supplementation served as the control. Based on our
previous SDSC work [3], we hypothesized that primed cells in 2D
culture would differentially express some extracellular matrix
(ECM) proteins associated with cartilage.
Materials and Methods
Ethics Statement
The dog tissue used in the studies was from waste (discarded)
tissues from dogs euthanized for other purposes and are therefore
IACUC exempt. The healthy, control tissue was obtained from
University of Missouri (Manuscript author: James L. Cook) after
being euthanized for other purposes. The study ‘‘Canine Models
for Diagnosis and Treatment of Cartilage Pathology’’, that
produced the original canine work, was approved by IACUC
from the University of Missouri-Protocol Number 3447.
Tissue Harvesting and Cell Expansion
Cartilage and synovial tissue were harvested from adult knee
joints from dogs euthanized for other purposes. Typically, both
hind limbs were harvested from each animal and pooled together
for the study. Cartilage and synovium were digested using type IV
collagenase (310 U/mg, Worthington) in medium containing 10%
(v/v) fetal bovine serum (FBS) (Atlanta Biologicals) at 37uC in a
humidified 5% CO2 atmosphere. Digested cells were filtered
through a 70 mm porous mesh and remaining tissue was discarded.
Chondrocytes were cultured in high-glucose Dulbecco’s modified
Eagle’s medium (hgDMEM, GIBCO) at a density of 226103 cells/
cm2 and SDSCs in alpha-minimum essential medium (a-MEM,
GIBCO) at a density of 1.766103 cells/cm2, both with 10% (v/v)
FBS and 1% (v/v) antibiotic-antimycotic (100 U/mL penicillin,
100 mg/mL streptomycin and amphotericin B) (PSAM, from
GIBCO), denoted as passage 1 (P1). To determine the effects of
priming cells towards a chondrogenic lineage in 2D culture,
culture media was supplemented with a cocktail of growth factors
(1 ng/mL TGF-b1, 5 ng/mL bFGF, and 10 ng/mL PDGF-BB
for the ‘primed’ group) [3,25,34]. Cells expanded without the
cocktail of growth factors served as the control or ‘unprimed’
group. When cells reached 80–90% confluence, they were
detached from the flask with 0.05% trypsin/0.53 mM EDTA
(Mediatech) and replated at the same initial density (P2). When
plated cells reached 80–90% confluence at P2, chondrocytes and
SDSCs (unprimed and primed) were harvested for flow cytometry
and proteomics analyses (Fig. 1). Cultures were fed three times per
week. Proliferation rate was calculated at each passage using the
doubling time formula: td = tc 6 ln(2)/ln(final/initial), where:
td = doubling time (days), tc = time in culture (days), final = number
of cells harvested, initial = number of cells initially seeded.
Flow Cytometry
At P2, chondrocytes and SDSCs were resuspended in
phosphate-buffered saline (PBS, GIBCO) containing 2 mM
EDTA (GIBCO) and fluorescein isothiocyanate (FITC)- or
phycoerythrin (PE)-conjugated monoclonal antibodies. Unstained
cells were used as a fluorescence negative control. Antibodies
against CD31 (Abcam), CD34 (Abcam), and CD45 (Invitrogen)
were used as negative indicators. CD31 (PECAM-1) is an
endothelial cell marker; CD34 and CD45 (LCA) are hematopoi-
etic cell markers. Antibodies against MSC markers, CD105
(endoglin, Abcam), CD151 (PETA-3, BD Pharmigen), and
CD166 (ALCAM, BioLegend) were also used. Cells were
incubated in the dark at room temperature for 15 minutes, after
which they were washed and resuspended in 0.5 mL PBS
containing 2 mM EDTA. Cell fluorescence was evaluated by flow
cytometry using a FACSCalibur flow cytometer (Becton Dick-
inson). The resulting data were analyzed by FlowJo software
(version 9.3.2).
Proteomics Analyses
A label-free protein profiling technique for mass spectrometry-
based shotgun proteomics was performed using a NanoAcquity
liquid chromatograph and a Synapt G2 HDMS QTOF mass
spectrometer (Waters Corp.). Cells were washed with ice cold PBS,
lysed in 0.3% SDS, TRIS-buffered saline with 1% Protease
Inhibitor Cocktail (Sigma-Aldrich), precipitated using a methanol/
chloroform extraction and then dissolved in 0.1% RapiGestTM SF
detergent-containing (Waters Corp.) 50 mM ammonium bicar-
bonate. Dithiothreitol was added and the solution was sonicated
and boiled for 5 minutes. Protein concentration was determined
using the Bradford Protein Assay (Bio-Rad). Cysteines were
alkylated with iodoacetamide. Proteins were digested with trypsin
and 50 fmol of a digest of yeast alcohol dehydrogenase was added
as an internal detection control. The mass spectrometer was
equipped for traveling wave ion mobility spectrometry (TWIMS).
Ion mobility provided separation on the basis of shape and cross-
sectional area, in addition to the conventional mass-to-charge
ratio. The use of ion mobility for shotgun proteomics has been
demonstrated to be effective in increasing proteome depth of
coverage [35,36]. Three independent biological replicates from
three separate cultures were analyzed. For each replicate, three
120 min liquid chromatography (LC)/mass spectrometry (MS)
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runs were carried out, providing a total of 36 chromatograms (nine
replicate analyses for each group) in resolution/ion mobility mode.
Spectra were recorded with a 0.6 second scan time, analyzed with
ProteinLynx Global Server V.2.5, RC9, (Waters Corp.) on a
Lenovo D20 Workstation with Xeon Processor equipped with a
NVIDIA Tesla C2050 graphics processing unit (GPU) processor
with 448 CUDA cores. Data was searched against an NCBI
Refseq database of canine sequences derived from Release 47.
This database containing 33,335 canine sequences (18,873,091
residues). Accurate mass and retention time matches of precursors
were compared across all LC/MS runs for label-free intensity-
based quantitation were performed with Rosetta Elucidator
software Ver. 3.3.0.1.SP3_CRE52.21 (Ceiba Solutions, Inc.) as
described previously [33]. Statistical analyses were generated by
Elucidator with p-values calculated from an application of an error
model developed for large-scale microarray data as adapted for
proteomics within the Elucidator program. Protein ratio p-values
for differential expression were calculated by the Elucidator
program using the xdev parameter [37,38].
The combination of label-free MSE data acquisition and post-
processing with Elucidator data mining software for accurate mass
and retention time matching is validated independently by other
groups [35,39–41]. From one C-P sample, all three chromato-
grams were outliers (derived from this one sample), were excluded
from the dataset based as typical on visual inspection [42] and
principal component analysis (data not shown). This individual
sample may have had some aberrant culture problem or problem
with protein extraction. Such exclusions are a normal prerequisite
for analysis of proteomics data [42].
In order to better understand the relevance of the resulting
canine proteins and for pathway analysis, canine Protein GI
numbers were converted into official gene symbols using the
DAVID conversion tool found at http://david.abcc.ncifcrf.gov/
conversion.jsp. Following this, canine official gene symbols were
converted to their human equivalent (when available) using
Homologene on NCBI. UniProt [43] was used to generate all of
the annotated protein data. Finally, the DAVID tool [44] was used
as an interface to the Kyoto Encyclopedia of Genes and Genomes
(KEGG) [45] pathway repository at Kyoto University to generate
pathway diagrams that illustrate some possible relationships from
the proteomics data.
In vitro Chondrogenic Differentiation
Chondrogenic differentiation of canine chondrocytes and
SDSCs at P2 was evaluated in a 28-day micropellet culture study
[13]. Briefly, 0.56106 cells were centrifuged (3006g for 7 min) in
15 mL conical polypropylene tubes (Becton Dickinson) and the
resulting pellet was cultured in 0.5 mL of chondrogenic medium
(hgDMEM, 1% (v/v) PSAM, 1% (v/v) ITSTM+Premix (BD
Biosciences), 100 mg/mL sodium pyruvate (Sigma), 50 mg/mL L-
proline (Sigma-Aldrich), 0.1 mM dexamethasone (Sigma-Aldrich),
with 50 mg/mL ascorbate-2-phosphate (Sigma-Aldrich) and
10 ng/mL TGF-ß3 (R&D) added fresh during each media
change. SDSC pellets were additionally treated with 500 ng/mL
bone morphogenetic protein-2 (BMP-2, GenScript). All chondro-
cyte and SDSC pellets were fed twice per week.
Biochemical Analysis
Time points for biochemical analyses were conducted on days 0,
14 and 28. Pellets were digested in proteinase K solution overnight
at 56uC, as previously described [46]. Biochemical analysis was
performed to determine the glycosaminoglycan (GAG) content
using the dimethylene blue assay [47]. In addition, the orthohy-
droxyproline assay [48] was used to assess collagen content.
Overall collagen content was calculated by assuming a 1:7.64
orthohydroxyproline-to-collagen mass ratio [49]. The DNA
content was determined using the PicoGreen kit (Invitrogen),
according to the manufacturer’s standard protocols. GAG and
collagen content was normalized to DNA content.
Statistical Analysis
Statistics were performed using a student’s t-test to compare
groups (primed vs. unprimed in both chondrocytes and SDSCs).
Figure 1. Schematic of experiments. Cells isolated from canine cartilage and synovium were cultured in 2D with (primed, -P) or without
(unprimed, -U) a growth factor cocktail (see Materials and Methods). Surface marker expression by flow cytometry and label-free proteomic profiling
were assessed in chondrocytes and SDSCs at passage 2 (P2). Cells were subsequently evaluated for chondrogenic capacity in 3D pellet culture at
passage 2 (P2).
doi:10.1371/journal.pone.0088053.g001
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Results were considered to be significant for p#0.05. Data was
analyzed using GraphPad Prism software (version 4.0c).
Results
Cell Proliferation
Treatment with the growth factor cocktail resulted in changes in
morphology and proliferation of cells. Within a few hours of
plating, both SDSCs and chondrocytes had adhered to the tissue
culture treated plastic. Non-adherent cells were removed from
cultures 48 hours after plating by changing the media. At P4,
unprimed cells were more widespread over the surface and showed
a myoblast-like morphology while primed cells displayed a more
elongated, spindle shape (Fig. 2).
The doubling times from P1 to P4 for each cell line (unprimed
chondrocytes: C-U; primed chondrocytes: C-P; unprimed SDSCs:
S-U; primed SDSCs: S-P) are shown in Figure 3. For each cell
type (chondrocytes and SDSCs), primed cells clearly proliferated
more rapidly than unprimed cells, as seen by the doubling rates
(chondrocytes: p,0.001 at P1 and P4, p,0.01 at P2; SDSCs: p,
0.01 at P2, P3, and P4).
Flow Cytometry
Cell surface marker expression was analyzed for canine
chondrocytes and SDSCs at P2 (Table 1). The expression of
CD31 (endothelial cell marker), CD34, and CD45 (hematopoietic
cell markers) was ,5% for all groups and no differences were
detected between the groups. The highest expression of CD105 (a
MSC marker) was seen in S-P (79%, p,0.001; S-P vs. S-U). Both
primed SDSCs and chondrocytes showed similar expression of
CD151 (, 60%) (Table 1). Surprisingly, S-U showed the highest
expression (82%) of CD151 as compared to its expression in S-P
(59%) (p,0.05). However, the lowest expression of CD151 was
found in C-U (27%), roughly half of its expression in C-P (58%;
p,0.01). Another MSC marker, CD166, was positive (mean $
95%) in SDSCs, regardless of treatment. In chondrocytes, the
percentage of CD166-positive cells was higher in C-P (76%) (p,
0.01; C-P vs. C-U).
Proteomics Analyses
Proteomic analysis focused on 1,766 proteins from which three
or more peptides were detected (see Table S1). Criteria for further
protein selection were based on p-value, ratio between –P and –U
(considered of interest when the increase or decrease was .1.75-
fold), and peptide count, which allowed us to narrow our study to
357 proteins of interest (labeled as * in Columns BL to BM in
Table S1). SDSCs had a greater number of proteins of interest, in
that 172 proteins were up-regulated (the abundance of these
proteins was higher in S-P than in S-U cells), while only 21 were
up-regulated by priming in chondrocytes (see Table S1). To gain
insight into the biological significance of the altered proteins
during the priming treatment, the differentially expressed proteins
were categorized according to their reported biological functions.
Functional characterization of these 357 proteins of interest reveals
that more than 50% are involved in cellular organization
(including proteins whose primary function is in the ECM,
cytoskeleton, or membrane organization) and transcription,
protein synthesis, and turnover (see Table S1).
In primed chondrocytes, some ECM-related proteins were
down-regulated (i.e., abundance of these proteins was higher in C-
U than C-P). These included type I collagen, type II collagen (4-
fold decrease) (Fig. 4A), type V procollagen, type V collagen, type
XII collagen, which interacts with type I collagen, and aggrecan
(2.77-fold decrease) (Table 2). Thrombospondin 1, a marker of
articular cartilage, was less abundant in both primed chondrocytes
and SDSCs (1.82-fold decrease) (Table 3). In addition, other
proteins involved in synthesis and processing of ECM components
were also down-regulated: procollagen-lysine, 2-oxoglutarate 5-
dioxygenase 2 isoform b precursor which forms hydroxylysine
residues in Xaa-Lys-Gly- sequences in collagens, and lysyl oxidase
Figure 2. Morphological differences between unprimed and primed cells. Phase contrast micrographs (206) of canine chondrocytes and
SDSCs at passage 4 cultured unprimed (left side) or primed (right side). Scale bar = 50 mm. Initial plating density was 12.5-fold greater for
chondrocytes than SDSCs.
doi:10.1371/journal.pone.0088053.g002
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preproprotein isoform 1, which is responsible for the post-
translational oxidative deamination of peptidyl lysine residues in
precursors to fibrous collagen and elastin (Table 2). On the other
hand, tenascin, another ECM protein expressed in chondrocytes,
was up-regulated with priming (1.92-fold increase). Transforming
growth factor-beta induced protein IG-H3 precursor, which binds
to types I, II, and IV collagens, was highly up-regulated (6.39-fold
increase) in C-P too (Table 2). Additional proteins associated with
cell stress, rescue or defense, were more abundant in C-U,
including heat shock protein beta-1, alpha crystallin B chain,
nucleoredoxin, and stress-70 protein (Table 2).
In SDSCs, some transcription factors and protein products
linked to chondrogenic differentiation were down-regulated. Y-
box transcription factor, known to be a regulator of collagen
translation, and collagen alpha 1(III) chain precursor isoform 2,
present in most soft connective tissues along with type I collagen,
were down-regulated. In contrast, procollagen-lysine, 2-oxogluta-
rate 5-dioxygenase 1 precursor (Lysyl hydroxylase 1) (LH1)
isoform 3, which forms hydroxylysine residues in nascent collagen
chains, and type VI collagen, were both up-regulated in S-P cells.
Meanwhile, other ECM proteins, namely biglycan and lumican,
were down-regulated in S-P (3.45- and 2.7-fold decrease,
respectively). Integrin beta 1, a receptor for collagen and
fibronectin, and integrin alpha-5 precursor, a receptor for
fibronectin and fibrinogen, were both down-regulated (Table 4).
In general, our data suggest that S-P were metabolically more
active than S-U and most of the proteins whose level increases
metabolism and cellular energy were up-regulated. For example,
ATP synthases, in NAD, lipid, or carbohydrate biosynthetic
enzymes, as well as oxidative tricarboxylic cycle enzymes (see
Fig. S1), and mitochondrial respiratory chain components were all
Figure 3. Doubling times of canine chondrocytes and SDSCs. Doubling times of canine (A) chondrocytes (unprimed (C-U), primed (C-P)) and
(B) SDSCs (unprimed (S-U), primed (S-P)) from P1 to P4 (n = 5). Statistically significant differences relative to unprimed cells are represented as **p,
0.01 and ***p,0.001.
doi:10.1371/journal.pone.0088053.g003
Table 1. Phenotype of canine chondrocytes (C-U, C-P) and
SDSCs (S-U, S-P) at passage 2.
Expression
(%) C-U C-P S-U S-P
CD31 0.0260.02 0.0460.03 0.0660.07 0.0060.01
CD34 0.1360.14 0.1260.14 0.4860.46 0.1460.19
CD45 0.6360.31 1.2060.9 4.2563.09 1.1460.89
CD105 45.7869.65 35.1865.23 61.9065.46 78.8263.31***
CD151 26.6769.76 57.8063.61** 81.5769.61 59.0066.53*
CD166 52.5065.53 75.8367.18** 95.0063.49 96.2861.29
Percentages of positive cells are shown as mean percentage 6 SD (n = 5).
Statistically significant differences relative to unprimed cells are represented as
*p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0088053.t001
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Figure 4. Examples of differential protein expression in canine chondrocytes and SDSCs. A) Example of differential expression of collagen
alpha-1(II) chain. The plot represents one isotopic signal from the mass spectrum of peptide GFTGLQGLPGPPGPSGDQGASGPAGPSGPR at 1337.1 m/z
and 45.6 min retention time. Unprimed chondrocytes (C-U) cells exhibit strong accumulation of this protein, compared to primed chondrocytes (C-P)
samples or either S-U or S-P samples B) Example of differential expression of aminopeptidase N (CD13). Plot represents one isotopic signal from the
mass spectrum of peptide ESALLYDPQSSSIGNK at 854.9 m/z and 46.3 min retention time. Primed SDSCs (S-P cells) exhibit strong accumulation of this
protein in response to growth factor priming; in comparison, neither C-P nor unprimed SDSCs (S-U cells) show a significant signal.
doi:10.1371/journal.pone.0088053.g004









304376314 Tenascin 0 1.92 35
164665422 Aggrecan core protein precursor 3.5E-18 0.36 3
74004974 Collagen alpha 2(V) chain precursor 3.2E-17 0.42 22
73991481 Destrin (Actin-depolymerizing factor) (ADF) 9.0E-21 0.51 4
73990680 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 isoform b precursor 1.4E-40 0.52 25
73973310 Alpha 1 type XII collagen short isoform precursor isoform 2 2.2E-21 0.53 92
73971374 Transforming growth factor-beta induced protein IG-H3 precursor (Beta IG-H3) (Kerato-epithelin)
(RGD-containing collagen associated protein) (RGD-CAP)
7.0E-39 6.39 5
73970918 Stress-70 protein, mitochondrial precursor (75 kDa glucose regulated protein) (GRP 75)
(Peptide-binding protein 74) (PBP74) (Mortalin) (MOT) isoform 21
1.4E-18 0.46 3
73970573 Lysyl oxidase preproprotein isoform 1 0 0.32 8
73967750 Procollagen, type V, alpha 1 6.1E-43 0.43 23
73967327 Nucleoredoxin 1.2E-21 0.56 5
73958530 Mitogen activated protein kinase 3 9.9E-35 0.46 3
57085977 Alpha crystallin B chain (Alpha(B)-crystallin) (Rosenthal fiber component)
(Heat-shock protein beta-5) (HspB5) isoform 1
0 0.1 5
55742776 Collagen alpha-1(II) chain 0 0.25 10
50979116 Heat shock protein beta-1 0 0.38 8
50978940 Collagen alpha-2(I) chain precursor 0 0.53 52
50978774 Collagen alpha-1(I) chain precursor 4.5E-38 0.48 85
Most of the protein names are truncated from the full names listed in the database for simplicity.
doi:10.1371/journal.pone.0088053.t002
Growth Factor Priming of Chondrocytes and SDSCs
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e88053
up-regulated (see Table S1). Moreover, some enzymes involved in
glycine biosynthesis and collagen synthesis (D-3-phosphoglycerate
dehydrogenase, C-1-tetrahydrofolate synthase), were also up-
regulated (Table 3, 4). Protein disulfide-isomerase A4 precursor
(Protein ERp-72) (ERp72) isoform 3, that catalyzes the rearrange-
ment of -S-S- bonds in proteins and related to collagen
biosynthesis and assembly too, was also up-regulated (2.02-fold
increase) (Table 4). A number of proteins involved in proteasome-
dependent protein turnover (see Fig. S2), or amino acid turnover
(see Fig. S3), were increased in primed cells.
Proteomic data also documented the altered abundance of
proteins whose function it is to regulate the cell cycle or cell fate.
Endothelial protein C receptor (stem cell marker) was up-regulated
in both C-P (6.04-fold increase) and S-P (2.69-fold increase)
(Table 3). A marker typically used to identify stem cells,
aminopeptidase N (CD13), was 4.5-fold up-regulated in S-P
(Table 4) (Fig. 4B). CD63, a tetraspanin, was also up-regulated
(2.34-fold increase) (Table 4). As stated previously, S-P cells
showed greater proliferation than S-U cells and proteins associated
with cell cycle, cell division, and DNA replication were mostly up-
regulated (Table S1).
A variety of proteins known to regulate the cytoskeleton,
subcellular organization, or the mechanics of secretion, were
regulated by priming. Therefore, the majority of proteins
associated with the cytoskeleton (actin, microtubules, actin binding
proteins (tropomyosin, drebrin, and stathmin that regulate
microtubule remodeling), and myosin and dynactin involved in
cellular and organelle motility and secretion) were down-regulated
(see Table S1). Other actin-remodeling proteins were differentially












225637546 Aminopeptidase N 0 4.50 9
158819069 Prohibitin 1.3E-41 1.80 12
74004777 Collagen alpha 1(III) chain precursor isoform 2 0 0.54 19
74001592 Collagen, type VI, alpha 1 precursor 0 3.17 11
73996304 Integrin alpha-5 precursor (Fibronectin receptor alpha subunit) (Integrin alpha-F) (VLA-5) (CD49e) 0 0.47 31
73978407 Protein disulfide-isomerase A4 precursor (Protein ERp-72) (ERp72) isoform 3 0 2.02 21
73971652 Gelsolin precursor (Actin-depolymerizing factor) (ADF) (Brevin) (AGEL) isoform 4 0 3.31 6
73968271 CD63 antigen (Melanoma-associated antigen ME491) (Lysosome-associated 1membrane glycoprotein 3)
(LAMP-3) (Ocular melanoma-associated antigen) (OMA81H) (Granulophysin) (Tetraspanin-30) (Tspan-30)
0 2.34 7
73964198 C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) 0 2.01 28
73963026 Cofilin 2 0 2.06 7
73954721 Transgelin isoform 2 2.1E-30 0.35 3
73950968 Nuclease sensitive element binding protein 1 (Y-box binding protein-1) (Y-box transcription factor) (YB-1)
(CCAAT-binding transcription factor I subunit A) (CBF-A) (Enhancer factor I subunit A) (EFI-A)
(DNA-binding protein B) (DBPB)… isoform
0 0.46 24
73950916 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 precursor (Lysyl hydroxylase 1) (LH1) isoform 3 0 2.24 3
73948624 Integrin beta 1 isoform 1D precursor 9.3E-29 0.46 25
57097203 Lumican precursor (Keratan sulfate proteoglycan lumican) (KSPG lumican) 2.3E-31 0.37 18
50979010 Biglycan precursor 1.3E-31 0.29 21
Most of the protein names are truncated from the full names listed in the database for simplicity.
doi:10.1371/journal.pone.0088053.t004





















73999965 Thrombospondin 1 precursor 0 0 0.55 0.55 45
73992265 Endothelial protein C receptor precursor (Endothelial cell protein C
receptor) (Activated
protein C receptor) (APC receptor) (CD201 antigen)
0 1.1E-41 6.04 2.69 4
73981286 D-3-phosphoglycerate dehydrogenase (3-PGDH) 7.7E-38 0 0.54 1.98 16
73954763 73954765 Dihydrolipoamide S-acetyltransferase (E2 component of pyruvate
dehydrogenase
complex) isoform 2
3.1E-18 0 2.01 2.94 3
Most of the protein names are truncated from the full names listed in the database for simplicity.
doi:10.1371/journal.pone.0088053.t003
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expressed, including transgelin (down-regulated) or cofilin and
gelsolin (up-regulated) (Table 4).
Biochemical Analysis
After 28 days in culture, chondrocyte pellets showed significant
differences in GAG content (p,0.001), with 62.9565.69 GAG/
DNA in C-P pellets and 43.0765.19 GAG/DNA in C-U pellets
(Fig. 5A). In contrast, C-P pellets showed a higher collagen content
than C-U pellets at day 14 (p,0.05), but a similar level by day 28
for both C-P and C-U cells (Fig. 5B). A significant increase in
GAG and collagen content was detected in S-P pellets
(31.8264.39 GAG/DNA and 25.3964.41 collagen/DNA) com-
pared to S-U pellets (15.9262.24 GAG/DNA and 10.6762.82
collagen/DNA) (p,0.001) at day 28 (Fig. 5C, D), while no
significant differences in DNA content were found over culture
time or between groups (data not shown).
Discussion
The aim of this study was to prime canine chondrocytes and
SDSCs with a cocktail of growth factors that increases their
potential for chondrogenic differentiation, and to identify differ-
entially regulated cartilage proteins. The results from this study
could potentially be used to identify predictors of cells’ utility in
cartilage tissue engineering protocols. The current study demon-
strated that growth factor priming had a much greater effect on
SDSCs than on chondrocytes, as seen by the number of proteins
differentially expressed in 2D between primed and unprimed cells,
and the differences in GAG and collagen content in 3D pellet
culture. Primed SDSCs appear to retain their stem cell potential,
although some collagen-related proteins, indicative of differenti-
ation, were up-regulated, which could be significant in their
future tendency for chondrogenic differentiation. In contrast,
chondrocytes, which start out in a differentiated state, dedifferen-
tiated over the culture period in 2D. Moreover, a dramatic
increase in cell number (doubling time), especially in SDSCs, was
observed. After 4 weeks of incubation, cells in pellet cultures
adopted a chondrocytic fate; GAG and collagen content increased
in a time-dependent manner. Recent studies have found that
cultured chondrocytes show better chondrogenic differentiation
ability than human MSCs [50,51]. These studies are consistent
with our results that chondrocytes produced more GAG than
SDSCs in pellet culture.
Although SDSCs are distinct from bone marrow-derived MSCs,
they are similar in their surface epitope expression [21]. To date,
no epitope unique to only SDSCs has been identified [21].
However, since SDSCs have been characterized as MSCs, surface
epitopes specific to MSCs are used for analysis. Of the surface
markers expressed by SDSCs, CD105 binds TGF-b1 and TGF-b3
with high affinity. Thus, CD105 may be a required mediator of
TGF-b signaling during chondrogenic differentiation of MSCs
[52]. Further, it was found that the CD105-positive subpopulation
of MSCs from human synovial membrane differentiated toward
chondrocyte-like cells [53]. In our study, this marker was more
highly expressed in S-P than S-U, and S-P cells differentiated
towards chondrocytes more fully than S-U cells, based on their
increased GAG and collagen content in pellet culture. CD166,
another MSC marker [54], was positive in both S-U and S-P cells,
although its expression was significantly higher in C-P than C-U,
which may be attributable to the observed dedifferentiation of the
chondrocytes.
In vitro culture conditions are important in determining the
proteome of cells. For example, culturing bone marrow-derived
stem cells with bFGF prolonged the cells’ differentiation potential
[55]. In agreement with Solchaga et al., who showed that human
bone marrow-derived MSCs expanded in the presence of bFGF
Figure 5. Biochemical properties of canine chondrocyte- and SDSC-pellet culture. (A, C) Glycosaminoglycan (GAG) content (g) normalized
to DNA (g). After 28 days in culture, primed cells produced significantly more GAG/DNA. (B, D) Collagen content (g) normalized to DNA (g). Primed
SDSCs (S-P cells) produced more collagen after 14 or 28 days. Results are shown as mean 6 SD (n = 5). Statistically significant differences relative to
unprimed cells are represented as *p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0088053.g005
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were smaller in size and faster growing than cells without bFGF
supplementation [56], both canine primed SDSCs and chondro-
cytes showed spindly morphology and proliferated more rapidly.
The first proteomic analysis of human bone marrow-derived
MSCs used 2D gels to identify differentially expressed proteins by
mass spectrometry [57]. In recent years several key technological
developments have significantly advanced both proteomic char-
acterization and biomarker discovery [31]. Since the initial report
by Colter et al., proteomics has been used to identify biomarkers
implicated in cell migration in diverse tissues including bone
marrow, umbilical cord blood, and placenta [58]. In our study,
identification of differentially expressed proteins was based on
label-free shotgun mass spectrometry and ion mobility spectrom-
etry, which together enhance peptide resolution, and provide
orthogonal separation of peptides in the gas phase to increase
detection and sequence coverage of proteins. The label-free
protein profiling approach has been utilized previously in our
laboratory to characterize human adipose-derived stem cells [33].
However, our current study presents the first proteomic profile of
SDSCs upon growth factor cocktail stimulation.
Park et al. summarized the proteome identified for human
mesenchymal stem cells [59]. It is noteworthy that among the
proteins Park et al. identified, some were also identified as proteins
of interest in our SDSC study, such as prohibitin, type VI collagen,
and CD63, which were all up-regulated in S-P cells. Senescent
cells down-regulate prohibitin expression [59]. Thus, S-U cells
showed a lower abundance of this protein compared to S-P cells,
which could be attributed to their reduced proliferation. More-
over, another stem cell surface marker (CD63) we identified in
SDSCs is also expressed on human articular chondrocytes [60]
and human marrow stromal cells [61]. Another protein we
identified as being up-regulated in S-P has been reported to be a
stem cell surface marker, CD13 [54]. However, we found that
other proteins previously identified in the MSC proteome, such as
transgelin, integrin beta 1, LIM and SH3 domain protein 1,
peptidylprolyl isomerase A and lumican [59], were down-
regulated in SDSCs (see Table S1).
The presence of smooth muscle proteins was previously
demonstrated in bone marrow-derived MSCs [57] and adipose-
derived MSCs [62]. However, several isoforms of tropomyosin
and a–tubulin were down-regulated in S-P cells (see Table S1).
Small leucine-rich proteins, such as decorin, fibromodulin,
lumican, and biglycan, which interact with collagen fibrils and
influence their fibrillar architecture and function [63], were mostly
unchanged, but two of these, lumican and biglycan, were down-
regulated in S-P cells. Cartilage oligomeric matrix protein
(COMP), a large pentameric glycoprotein and a member of the
thrombospondin group of extracellular proteins, also binds
collagen and is thought to mediate cell–matrix interactions
[64,65]. Although we did not identify COMP in this study, we
did identify a COMP-related protein, protein disulfide isomerase,
which functions in the processing and transport of wild-type
COMP, in chondrocytes [66]. In addition, protein disulfide
isomerase helps in the folding of many other extracellular proteins;
thus it was more abundant in S-P cells, where it acts as a subunit
for prolyl 4-hydroxylase in collagen biosynthesis, and as a
molecular chaperone for assembly of procollagen [67].
In situ, articular chondrocytes reside in a hypoxic environment
and therefore rely primarily on anaerobic glycolysis to generate
ATP [68]. Our study found few differences in proteins involved in
energy production between C-P and C-U samples, potentially due
to the fact that the culture environment we used was not hypoxic.
However, one exception was dihydrolipoamide S-acetyl transfer-
ase, a component of the pyruvate dehydrogenase complex (one of
the links between glycolysis and the Krebs cycle) [69]. This
enzyme was up-regulated in both C-P and S-P cells. In fact, most
of the differentially expressed proteins involved in cellular
metabolism and energy production were up-regulated in S-P cells.
aB-crystallin (heat-shock protein b5) is a member of the small
heat-shock protein family and it functions to protect cells against
stress factors, such as heat shock, oxidative stress, osmotic shock,
and chemical stress. A decrease of aB-crystallin was associated
with a decrease in collagen type II and aggrecan; a decrease in
both of the latter typifies dedifferentiation of chondrocytes [70].
Our results appear similar: we found aB-crystallin, type II
collagen, and aggrecan were all down-regulated in C-P. Another
small heat shock protein, heat shock protein beta 1, was down-
regulated in C-P cells, similar to decreases that had been reported
for this protein after stimulation with TGF-b in human bone
marrow-derived MSCs [31].
As observed with other MSC types [59], the global proteome of
SDSCs would be a more reliable predictor of chondrogenic
potential than focusing only on specific markers. Thus, it was
shown by proteomic profiling that the use of TGF-b1, bFGF, and
PDGF-BB to stimulate canine chondrocytes and SDSCs in 2D
culture is accompanied by remodeling of the cytoskeleton and
other proteins associated with the ECM, and led to better
chondrogenic differentiation in 3D culture. Consequently, under-
standing the importance of multiple proteins within the protein
profile obtained by priming may elucidate the underlying
mechanism by which this growth factor cocktail mediates better
chondrogenesis. Specifically, most proteins associated with carti-
lage were down-regulated in chondrocytes including collagens,
aggrecan, thrombospondin 1, D-3-phosphoglycerate dehydroge-
nase, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 isoform b
precursor, and lysyl oxidase preproprotein isoform 1. However,
some collagen-related proteins were up-regulated in SDSCs,
including type VI collagen, protein disulfide isomerase, D-3-
phosphoglycerate dehydrogenase, and C-1 tetrahydrofolate syn-
thase. These results argue that priming mediated a partial
dedifferentiation of chondrocytes and a partial differentiation of
SDSCs as seen by the regulation of a series of ECM related
proteins, both of which allowed expansion of cells that have great
chondrogenic potential once placed in 3D culture. That is, ECM
components of the priming-induced protein profile may be directly
linked with the higher GAG and collagen production demonstrat-
ed in pellet culture, both in this study and in constructs seeded
with primed SDSCs in previous work [3]. The results of the
present study also verify that the label-free profiling proteomics
technique is a robust, consistent, and automated technology that is
suitable for high throughput quantitative proteomics studies.
Future insights in this field will allow for the identification of
biomarkers that could produce better tissue engineered cartilage.
Supporting Information
Proteins detected in this study with three or more peptides are
listed in the spreadsheet Table S1. This table includes protein
name, NCBI GI number, additional NCBI GI numbers matching
same peptides, canine gene, corresponding human gene, human
protein name, human keywords, human subcellular location,
human gene ontology (GO), human pathway, human catalytic
activity, human function, human tissue specificity, intensity, p-
values, ratio between primed and unprimed, peptide count, and
functional characterization of the 357 proteins differentially
expressed in this study. All raw mass spectrometry data files will
be uploaded and freely accessible to the global scientific
community at the community-supported Chorus project website
(http://chorusproject.org).
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Supporting Data Figures S1, S2 and S3 were derived by
searching differentially expressed proteins in the DAVID and
KEGG databases. This material is available free of charge via the
Internet at http://www.plosone.org.
Supporting Information
Figure S1 Citrate cycle diagram by KEGG. Some enzymes
that were identified as protein of interest from the proteomics data
and participate in citrate cycle were up-regulated in SDSCs
(represented as red arrows).
(TIF)
Figure S2 Proteasome diagram by KEGG. Some protea-
somal proteins that were identified of interest from the proteomics
data were up-regulated in SDSCs (represented as red arrows).
(TIF)
Figure S3 Valine, leucine, and isoleucine degradation
diagram by KEGG. Some enzymes that were identified of
interest from the proteomics data and participate in valine,
leucine, and isoleucine degradation were up-regulated in SDSCs
(represented as red arrows).
(TIF)
Table S1 Differentially Expressed Proteins. This table
includes protein name, NCBI GI number, additional NCBI GI
numbers matching same peptides, canine gene, corresponding
human gene, human protein name, human keywords, human
subcellular location, human gene ontology (GO), human pathway,
human catalytic activity, human function, human tissue specificity,
intensity, p-values, ratio between primed and unprimed, peptide
count, and functional characterization of the 357 proteins
differentially expressed in this study.
(XLS)
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